Brief: Immunotech Biopharm Says Entered Construction Agreement
March 29 (Reuters) - Immunotech Biopharm Ltd 6978.HK :
* ENTERED CONSTRUCTION AGREEMENT WITH CHINA CONSTRUCTION
THIRD
ENGINEERING BUREAU GROUP
* CONTRACT FOR CONSTRUCTION OF RESEARCH AND DEVELOPMENT &
INDUSTRIALISATION BASE IN BEIJING, PRC FOR RMB665 MILLION
Source text for Eikon: urn:newsml:reuters.com:*:nHKS6YBxry
Further company coverage: 6978.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Immunotech Biopharm
See all newsBrief: Immunotech Biopharm Gets Approval In Sept 2025 For Clinical Translational Application Of Atl In Hainan
Brief: Immunotech Biopharm Receives Notice Of Rejection For Conditional New Drug Application For EAL Dated 27 April 2026
Brief: Trading In Shares Of Immunotech Biopharm Will Be Halted At 1:00 PM On April 28, HKEX Says
Brief: Immunotech Biopharm Posts Loss And Total Comprehensive Expense For Year Attributable Rmb230.8 Million
Brief: Immunotech Biopharm Subscribes To Structured Deposit Product With Investment Value Of RMB50 MLN